Cloopen, also known as Ronglian and Yuntongxun, priced its shares at $16 to raise $320m in an initial public offering that provided an exit for Telstra Ventures and New Oriental.

WuXi AppTec and New World Development-backed Adagene has raised close to $140m in its initial public offering after having secured $155m in equity financing.

Caltech spinout Talis Biomedical has raised more than $220m in an initial public offering on the Nasdaq Global Market.

NexImmune priced shares at $17 to raise $110m in an upsized offering, enabling Amgen and Pfizer to exit the Johns Hopkins University spinout.

The hearing loss treatment developer has raised more than $127m in its initial public offering that offered exits to Alphabet, GlaxoSmithKline and Regeneron.

Coupang is reportedly looking to achieve a $50bn market cap following a planned listing that would offer an exit to both SoftBank and its Vision Fund.

NexImmune priced shares at $17 to raise $110m in an upsized offering, enabling Amgen and Pfizer to exit the Johns Hopkins University spinout.

The Petco-backed pet services provider is set to be valued at about $1.6bn in a deal that will involve it listing on the Nasdaq Capital Market.

Adways, Fidelity, Nissay Capital, Opt, SMBC Venture Capital and Voyage Ventures are all set to exit the C2C skills marketplace operator in an offering on TSE’s Mothers Market.

The CBRE, Ericsson, AMD, News Corp, PTC and Qualcomm-backed spatial modelling technology provider will list on the Nasdaq Capital Market through the deal.